Annotation Detail for MPHOSPH8
Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MPHOSPH8 mRNA | decreases expression | 19150397
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of MPHOSPH8 mRNA | decreases expression | 15336504
|
C065180 |
fluvastatin |
[zoledronic acid co-treated with fluvastatin] results in increased expression of MPHOSPH8 mRNA | affects cotreatment|increases expression | 16996129
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MPHOSPH8 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D012402 |
Rotenone |
Rotenone results in decreased expression of MPHOSPH8 mRNA | decreases expression | 19013527
|
C088658 |
zoledronic acid |
[zoledronic acid co-treated with fluvastatin] results in increased expression of MPHOSPH8 mRNA | affects cotreatment|increases expression | 16996129
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.79 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.94 | 20200999 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
5.31 | 15867366 11697798 16778634 16121404 17312309 19442620 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
5.03 | 11869084 18496637 16769263 8053405 15845617 18404659 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
3.27 | 18695136 16096432 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
3.63 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
3.97 | 18507039 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.93 | 20889678 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.99 | 16142594 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.13 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.09 | 19236843 20131406 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
6.29 | 16234978 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 19176532 18467677 16221962 19772884 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
4.50 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
5.37 | 18089816 19622757 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.71 | 12669777 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
5.09 | 18089816 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.91 | 15890375 20007298 16377806 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
3.91 | 17312309 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.85 | 16675582 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
8.90 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
8.90 | 18089719 16996129 19621390 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
3.74 | 19139120 15867366 17312309 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.08 | 17405874 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
4.12 | 18619942 15790535 17356569 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.83 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
4.21 | 17882678 |
MESH:D010146 |
Pain |
|
zoledronic acid |
4.20 | 16475674 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
3.07 | 18191903 19232380 16140633 11445065 16412576 11535288 18619942 19114014 15451049 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.38 | 18197244 15795934 15574749 15927086 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
4.19 | 12438248 19103299 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
5.31 | 16121404 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.81 | 8532709 |